Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are extensively evaluated for the risk of suicidal behaviors or ideation; the influence of psychiatric history or obesity on this potential effect remains to be investigated. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.